CLSD
Price
$4.04
Change
+$0.31 (+8.31%)
Updated
Sep 26 closing price
Capitalization
21.15M
50 days until earnings call
IMNN
Price
$5.18
Change
-$0.01 (-0.19%)
Updated
Sep 26 closing price
Capitalization
13.06M
49 days until earnings call
Interact to see
Advertisement

CLSD vs IMNN

Header iconCLSD vs IMNN Comparison
Open Charts CLSD vs IMNNBanner chart's image
Clearside Biomedical
Price$4.04
Change+$0.31 (+8.31%)
Volume$99.12K
Capitalization21.15M
Imunon
Price$5.18
Change-$0.01 (-0.19%)
Volume$32.97K
Capitalization13.06M
CLSD vs IMNN Comparison Chart in %
Loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSD vs. IMNN commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSD is a StrongBuy and IMNN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (CLSD: $4.04 vs. IMNN: $5.18)
Brand notoriety: CLSD and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLSD: 25% vs. IMNN: 17%
Market capitalization -- CLSD: $21.15M vs. IMNN: $13.06M
CLSD [@Biotechnology] is valued at $21.15M. IMNN’s [@Biotechnology] market capitalization is $13.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSD’s FA Score shows that 0 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • CLSD’s FA Score: 0 green, 5 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNN is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSD’s TA Score shows that 5 TA indicator(s) are bullish while IMNN’s TA Score has 4 bullish TA indicator(s).

  • CLSD’s TA Score: 5 bullish, 3 bearish.
  • IMNN’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both CLSD and IMNN are a good buy in the short-term.

Price Growth

CLSD (@Biotechnology) experienced а +7.45% price change this week, while IMNN (@Biotechnology) price change was +4.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CLSD is expected to report earnings on Nov 18, 2025.

IMNN is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLSD($21.1M) has a higher market cap than IMNN($13.1M). IMNN YTD gains are higher at: -58.196 vs. CLSD (-71.649). CLSD has less debt than IMNN: CLSD (533K) vs IMNN (1.19M).
CLSDIMNNCLSD / IMNN
Capitalization21.1M13.1M161%
EBITDAN/A-14.79M-
Gain YTD-71.649-58.196123%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A4.73M-
Total Debt533K1.19M45%
FUNDAMENTALS RATINGS
CLSD vs IMNN: Fundamental Ratings
CLSD
IMNN
OUTLOOK RATING
1..100
510
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9795
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
2285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNN's Valuation (55) in the Medical Specialties industry is somewhat better than the same rating for CLSD (88) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew somewhat faster than CLSD’s over the last 12 months.

IMNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

IMNN's SMR Rating (100) in the Medical Specialties industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

IMNN's Price Growth Rating (95) in the Medical Specialties industry is in the same range as CLSD (97) in the Pharmaceuticals Major industry. This means that IMNN’s stock grew similarly to CLSD’s over the last 12 months.

CLSD's P/E Growth Rating (76) in the Pharmaceuticals Major industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that CLSD’s stock grew similarly to IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLSDIMNN
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 5 days ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGLS67.842.14
+3.26%
Tecnoglass
OWLT8.700.26
+3.08%
Owlet
SHG48.930.05
+0.10%
Shinhan Financial Group Co Ltd
FDUS20.18-0.29
-1.42%
Fidus Investment Corp
OSRH0.58-0.02
-3.32%
OSR Holdings Inc.

CLSD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLSD has been loosely correlated with ABVX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CLSD jumps, then ABVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
+8.31%
ABVX - CLSD
50%
Loosely correlated
+1.02%
IMNN - CLSD
30%
Poorly correlated
-0.19%
ANEB - CLSD
29%
Poorly correlated
-1.64%
BOLT - CLSD
29%
Poorly correlated
-2.00%
ACLX - CLSD
28%
Poorly correlated
+1.72%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with REPL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
-0.19%
REPL - IMNN
61%
Loosely correlated
+1.98%
ABVX - IMNN
57%
Loosely correlated
+1.02%
SPRO - IMNN
41%
Loosely correlated
-2.58%
MRUS - IMNN
36%
Loosely correlated
+1.16%
CLSD - IMNN
30%
Poorly correlated
+8.31%
More